Carbapenem-resistant and other multidrug-resistant organisms in a South Indian tertiary care centre: A laboratory-based study
The Indian Journal of Medical Research · 2026
DOI: 10.25259/ijmr_103_2026 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Indian Journal of Medical Research, 2026. Verfasst von Arya S Kumar und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infection Control & Epidemiology, Amrita Institute of Medical Sciences & Research Centre, Kochi, Kerala, India. Hauptthemen laut MEDLINE: Carbapenems, Drug Resistance, Multiple, Bacterial. Die Arbeit nennt 16 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background and objectives Carbapenem-resistant gram-negative pathogens are associated with limited treatment options and poor clinical outcomes. This study assessed the prevalence, distribution, antimicrobial susceptibility, and clinical outcomes of multidrug-resistant organisms from intensive care units and related wards in a South Indian tertiary care hospital over three years.
Methods
A retrospective laboratory-based study was conducted between October 2022 to May 2025, analysed culture-positive specimens from the selected locations using hospital information system data. Multidrug-resistant organisms were defined according to international criteria. Organisms included carbapenem-resistant Enterobacterales , carbapenem-resistant Acinetobacter baumannii , carbapenem-resistant Pseudomonas aeruginosa , methicillin-resistant Staphylococcus aureus , vancomycin-resistant Enterococcus spp., and trimethoprim–sulfamethoxazole resistant Stenotrophomonas maltophilia. Demographics, specimen distribution, antimicrobial susceptibility, and outcomes were analysed using descriptive and inferential statistics.
Results
Of 8,704 specimens processed, 3,450 (39.6%) were culture-positive and 750 (34.2%) were multidrug-resistant. Carbapenem-resistant Enterobacterales accounted for (n=490,65.3%) of multidrug-resistant organisms, followed by carbapenem-resistant Acinetobacter baumannii (n=85,11.3%), carbapenem-resistant Pseudomonas aeruginosa (n=85,11.3%), methicillin-resistant Staphylococcus aureus (n=40,5.3%), vancomycin-resistant Enterococcus spp. (n=34,4.5%), and trimethoprim–sulfamethoxazole-resistant S. maltophilia (n=16,2.1%). Klebsiella pneumoniae predominated among carbapenem-resistant Enterobacterales isolates. Multidrug-resistant organisms were significantly more common in intensive care units (539/750,71.9%) and among patients aged >60 y (399/750,53.2%) ( P
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Infection Control & Epidemiology, Amrita Institute of Medical Sciences & Research Centre, Kochi, Kerala, India.
- Department of Medical Administration, Amrita Institute of Medical Sciences, Faridabad, Haryana, India.
- Department of Medical Administration, Amrita Institute of Medical Sciences & Research Centre, Kochi, Kerala, India.
Zitieren
APA
Kumar, A. S., Singh, S. K., John, M. S., H, S., Mohan, N., Sebastain, I. A., & S, V. (2026). Carbapenem-resistant and other multidrug-resistant organisms in a South Indian tertiary care centre: A laboratory-based study. The Indian Journal of Medical Research. https://doi.org/10.25259/ijmr_103_2026
Vancouver
Kumar AS, Singh SK, John MS, H S, Mohan N, Sebastain IA, et al. Carbapenem-resistant and other multidrug-resistant organisms in a South Indian tertiary care centre: A laboratory-based study. The Indian Journal of Medical Research. 2026. doi:10.25259/ijmr_103_2026
BibTeX
@article{Kumar2026,
author = {Kumar, Arya S and Singh, Sanjeev K and John, Meera Susan and H, Shreya and Mohan, Nimi and Sebastain, Irine Anna and S, Vaishnavi},
title = {Carbapenem-resistant and other multidrug-resistant organisms in a South Indian tertiary care centre: A laboratory-based study},
journal = {The Indian Journal of Medical Research},
year = {2026},
doi = {10.25259/ijmr_103_2026}
}
EUVIMED